CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Current Assets
Cash and cash equivalents	$ 11,103	$ 9,676
Short-term investments	0	774
Accounts receivable (net of allowance for doubtful accounts of $90 in 2020 and $86 in 2019)	7,577	6,778
Inventories (excludes inventories of $1,921 in 2020 and $1,480 in 2019 classified in Other assets - see Note 6)	6,056	5,978
Other current assets	4,607	4,277
Total current assets	29,343	27,483
Investments	1,251	1,469
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,182 in 2020 and $17,686 in 2019	15,789	15,053
Goodwill	20,067	19,425
Other Intangibles, Net	16,566	14,196
Other Assets	7,599	6,771
Total Assets	90,615	84,397
Current Liabilities
Loans payable and current portion of long-term debt	4,718	3,610
Trade accounts payable	3,448	3,738
Accrued and other current liabilities	11,182	12,549
Income taxes payable	1,266	736
Dividends payable	1,564	1,587
Total current liabilities	22,178	22,220
Long-Term Debt	26,156	22,736
Deferred Income Taxes	2,091	1,470
Other Noncurrent Liabilities	12,446	11,970
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2020 and 2019	1,788	1,788
Other paid-in capital	39,373	39,660
Retained earnings	49,724	46,602
Accumulated other comprehensive loss	(6,393)	(6,193)
Stockholders' equity before deduction for treasury stock	84,492	81,857
Less treasury stock, at cost: 1,047,935,095 shares in 2020 and 1,038,087,496 shares in 2019	56,850	55,950
Total Merck & Co., Inc. stockholders’ equity	27,642	25,907
Noncontrolling Interests	102	94
Total equity	27,744	26,001
Liabilities and Equity	$ 90,615	$ 84,397